Antibacterial Effect Combination of Moringa Leaf Extract (Moringa oleifera Lam.) and Amoxicillin against Staphylococcus aureus and Escherichia coli in Vitro
Abstract
Staphylococcus aureus and Escherichia coli often infect humans and risky cause antibiotics resistance including amoxicillin. This encourages us finding alternative active ingredients: Moringa oleifera leaf. This study evaluated antibacterial activity of combination of Moringa leaf extract (KDK) and amoxicillin (KA) against S. aureus and E. coli in vitro. The research methods with true experimental research with post-test control group design. KDK obtained by maceration. Four concentrations of KDK test materials (20, 30, 40, 50%) and 1 concentration of KA (3 mg/mL). Disc diffusion test method taken and the parameter measured: the diameter of the disc inhibition zone. Data analyzed by One-way ANOVA and further Tukey’s test. KDK+KA against S. aureus (20.77±1.79 – 21.33±1.74 mm)>KDK (11.45±0.21 – 12.45±0.28 mm) or KA (14.50±0.42 mm). KDK+KA against E. coli (15.53±0.71 – 17.87±0.42 mm)>KDK (9.00±0.28 – 10.30±0.42 mm) or KA (13.45±0.35 mm). A significant (p<0.05) was obtained between the combination group (KDK+KA) versus a group (KDK or KA). The combination of Moringa leaf ethanol extract and amoxicillin synergistically effected as antibacterial against S. aureus and E. coli in vitro.
References
2. Kern, W.V and Rieg, S. Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens. Clinical microbiology and infection 26. 2020; 151-157. https://doi.org/10.1016/j.cmi.2019.10.031. Accessed September 21, 2021.
3. Karlowsky, et al. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrobial agents and chemotherapy. 2002; 2540–2545. https://doi.org/10.1128/AAC.46.8.2540–2545.2002. Accessed August 21, 2021.
4. Islam, M, et al. Antibacterial activity of crab of amoxicillin against Staphylococcus aureus and Eschericia coli. Journal of Advanced Scientific Research. 2011; 2(4): 63-66.
5. Abou-Zeid, S.M et al. Moringa oleifera ethanolic extract attenuates tilmicosin-induced renal damage in male rats via suppression of oxidative stress, inflammatory injury, and intermediate filament proteins mRNA expression. Biomedicine and pharmacotherapy. 2021; 133.
6. Gomes, F et al. Plant phenolic extracts as an effective strategy to control Staphylococcus aureus, the dairy industry pathogen. Ind. Crops Prod. 2018; 112; 515–520.
7. Elza, S., Fakhrurrazi., Harris A. Uji antibakteri ekstrak daun kelor (Moringa oleifera l.) terhadap pertumbuhan bakteri Staphylococcus aureus. JIMVET. 2018; 2(3):373-379.
8. Chanda, S., and Rakholiya, K. Combination therapy: synergism between natural plant Extracts and Antibiotics Against Infectious Diseases. 2011; 520-529.
9. Kementerian Kesehatan Republik Indonesia. Daun kelor (Moringa oleifera folium). Farmakope herbal Indonesia 2. 2017; 209.
10. Dwidjoseputro. Dasar-Dasar Mikrobiologi. Penerbit Djambatan. 1998.
11. Maida, S. and Lestari, K. Aktivitas antibakteri amoksisilin terhadap bakteri gram positif dan bakteri gram negatif amoxiciillin. Jurnal Pijar MIPA. 2019; 8(5): 55. https://doi.org/10.29303/jpm.1029. Accessed August 21, 2021.
12. Agustie, A and Samsumaharto, R. Antibacterial activity test of moringa leaf extract (Moringa oleifera lam.) against Staphylococcus aureus bacteria. Biomedika 6 (2). 2013; 14-19.
13. Amalia, M. Uji aktivitas antibakteri ekstrak metanol daun kelor (Moringa oleifera l.) terhadap bakteri Escherichia coli dengan metode sumuran. 2021; 1-4.
14. Emelia, R, Safitri D, and Andriyani, H. Daun kelor (Moringa oleifera) sebagai antibakteri terhadap infeksi bakteri Escherichia coli. Jurnal infokes-politeknik piksi ganesha. 2021; 44-50.
15. Purnasari, C. Uji aktivitas antibakteri ekstrak etanol daun kelor (Moringa oleifera Lam.) terhadap bakteri patogen resisten antibiotik. 2013; 21-29.
16. Yunita, E, Permatasari, D, and Lestari D. Antibacterial activity of moringa leaves extract against Pseudomonas aeruginosa. Jurnal Ilmiah Farmako Bahari. 2020; 189-194. https://journal.uniga.ac.id/index.php/JFB. Accessed August 21, 2021.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.